| Literature DB >> 31905762 |
Phuong-Y Mai1, Marceau Levasseur1, Didier Buisson2, David Touboul1, Véronique Eparvier1.
Abstract
The emergence of multidrug resistant bacterial pathogens and the increase of antimicrobial resistance constitutes a major health challenge, leading to intense research efforts being focused on the discovery of novel antimicrobial compounds. In this study, endophytes were isolated from different parts of Sandwithia guyanensis plant (leaves, wood and latex) belonging to the Euphorbiaceae family and known to produce antimicrobial compounds, and chemically characterised using Molecular Network in order to discover novel antimicrobial molecules. One fungal endophyte extract obtained from S. guyanensis latex showed significant antimicrobial activity with Minimal Inhibitory Concentration on methicillin-resistant Staphylococcus aureus at 16 µg/mL. The chemical investigation of this fungus (Lecanicillium genus) extract led to the isolation of 5 stephensiolides compounds, four of which demonstrated antibacterial activity. Stephensiolide I and G showed the highest antibacterial activity on MRSA with a MIC at 4 and 16 µg/mL respectively.Entities:
Keywords: Lecanicillium sp.; Molecular Networking; antimicrobial; endophytes; latex; stephensiolides
Year: 2019 PMID: 31905762 PMCID: PMC7020175 DOI: 10.3390/plants9010047
Source DB: PubMed Journal: Plants (Basel) ISSN: 2223-7747
Figure 1Minimal Inhibitory Concentration (MIC) of the extract strains isolated from S. guyanensis latex on methicillin-resistant Staphylococcus aureus (MRSA).
Figure 2(A) Global Molecular Networks of 42 strain extracts isolated from S. guyanensis. The clusters from active extracts on MRSA are shown in pink. Clusters from BSNB-SG3.7 strain are surrounded by red. Cluster of analogues of stephensiolides from Lecanicillium sp. (BSNB-SG3.7) extract strain is surrounded in black. (B) Isolated compounds of BSNB-SG3.7 are shown in black and the predicted compounds are in red.
Figure 3Structures of the isolated compounds 1 to 5.
Antimicrobial activities of compounds 1–5.
| Compound | MIC on MRSA (µg/mL) |
|---|---|
|
| 4 |
|
| 32 |
|
| 16 |
|
| 128 |
|
| 32 |
|
| 16 |
|
| 0.6 |